Imugene Limited (ASX: IMU) is an immuno-oncology company in its clinical stage which is working in the field of development of a range of new and novel immunotherapies that basically activate the immune system of the patients having cancer and then eradicates and removes tumors developed in them.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK